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Statement of  the problem:  Depression is a common condition that is often under-
diagnosed and under-treated.  Depression screening in primary care is both a Healthy People 
2020 goal, and is being promoted through Medicare’s Annual Wellness Visit (AWV) benefit--
a preventive care screening visit that is free for Medicare Part B beneficiaries. 
!
Methods: A secondary analysis of  retrospectively collected electronic health record (EHR) 
data from 5,000 Medicare patients.  Quota-random sampling was used so that half  of  the 
patients had an AWV and half  of  the patients had at least one primary care visit during the 
study period (2010-2012).  Scores on the Patient Health Questionnaire, a validated patient-
reported depression screening tool, were collected from structured fields in the EHR. 
Bivariate and multivariable logistic regressions were used to determine the odds of  
depression screening and meeting quality measures for depression.  
!
Results: Overall, depression screening was low, at 17%.  In the cross-sectional analysis of  the 
patients’ index visit, AWV patients were not more likely to receive depression screening at a 
statistically significant level in either the bivariate or the multivariable model, after accounting 
for clustering at the physician level(OR 1.28 95%CI:0.86-1.94; OR 1.33 95%CI:0.88-2.00, 
respectively).   There was a clear clinic site effect of  depression screening with one site 
screening 78% of  AWV patients and 83% of  non-AWV patients and six sites screening none 
of  their patients.  In the adjusted longitudinal analyses, having multi-morbidity was 
associated with decreased odds of  receiving both depression and smoking status screenings 
compared to receiving neither or only smoking status screening by 28% after adjusting for 
race, age, and sex.(AOR: 0.72, 95%CI:0.52-1.0). 
ii
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Conclusions: Depression screening rates were low whether they were examined cross-
sectionally or longitudinally.  After adjusting for patient factors and clustering at the clinician 
and site level, the odds of  depression screening were not significantly different between 
patients who received an AWV visit and those who did not.  Our work shows that requiring 
depression screening as part of  a Medicare benefit is not a strong enough incentive to 
increase depression screening. 
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  Historically, much of  health care has been focused on physical health,1 however, 
mental health issues are both common and costly.2,3  Patients with mental health problems 
experience decreased quality of  life and increased mortality relative to the general 
population.4 One of  the most prevalent mental health diseases is depression, affecting 1 in 6 
older adults in the U.S..5,6  World-wide, major depressive disorder is a major cause of  total 
years-lived with disability.7  
 The interaction of  the burden of  depression and co-morbid disease has been widely 
studied.8  Persons reporting at least one chronic physical disease are more likely to report 
depression; and patients who report depression co-morbid with another physical disease 
have lower mean health scores compared to patients reporting two or more physical 
comorbidities.9  Depression after physical impairment has been shown to result in poorer 
long term recovery.10 
 Depression treatment is often effective11 but under-treatment is common.12,13  Older 
adults are often treated for depression in primary care as opposed to speciality care.13 
Patients with depression who are treated in primary care without staff-assisted depression 
care support, are less likely to have improved symptoms and are more likely to die.14,15  
Interventions in the primary care setting that have shown positive outcomes for patients 
with depression include providing educational materials, and a visit with a depression care 
manager in which depression care preferences were discussed.14,15   Without an explicit 
intervention, only 20% of  Medicare patients diagnosed with depression have at least one 
visit with a mental health specialist while 60% received an antidepressant.15 
  The U.S. Preventive Service Task force recommends depression screening only when 
“staff-assisted depression care supports are in place.”16 A systematic review found that 
screening for depression in older adults without “substantial staff-assisted depression care 
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supports” is not likely to improve depression outcomes.17 While increasing depression 
screening in primary care practices is a HealthyPeople2020 goal,2 the Canadian Task Force 
on Preventive Health Care did not recommend routine depression screening for adults.18 
 Initiatives are ongoing to systematize and incentivize screening to improve quality of  
care.  The National Quality Forum used depression as an example of  a patient-reported 
outcome that has been developed into a patient-reported quality measure.19 Starting in 2010, 
clinics in Minnesota are reporting the Patient Health Questionnaire (PHQ)-9 depression 
screening tool as part of  a quality measurement initiative.20  In 2011, the Centers for 
Medicare and Medicaid Services started paying for annual depression screening, as well as 
other preventive care screenings at no cost to the patient,21 but are reimbursed at high rates 
to providers.22  Further, screening for clinical depression is part of  Meaningful-Use Stage 2’s 
adult core 2014 clinical quality measures.23,24  In 2008, the United Kingdom began 
incentivizing collection of  patient reported outcomes; and the clearest benefits of  this 
program were improvements in care processes, including diagnosis of  depression.25   Yet, at 
least one peer-reviewed article suggested that the evidence did not support depression 
screening as a quality measure.26 
 With these current policy initiatives, and mixed evidence, assessing the value of  using 
patient-reported depression as a quality of  care indicator is vital.  Results from this study will 
therefore fill a clear gap in the literature since no study has looked at depression screening as 
a quality of  care indicator derived from electronic health records for older adults in a 
primary care setting, although it is this population for whom depression screening is being 
incentivized.  Results from this study will 1) assess impact of  a federal policy to promote 
preventive screening on depression screening practice; 2) provide insight regarding whether 
mental health screening (e.g. depression) occurs at the same frequency as physical health 
screening (e.g. tobacco); 3) assess patient factors that impact the rate of  completion of  
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quality measures. Most importantly, this study will help us understand the use of  depression 
screening as a patient-reported outcome measure, as well as assess whether there are 
potential disparities in care due to unintentional consequences of  these quality of  care 
incentives. 
Dissertation Objective 
Depressive symptoms increase in older age.27  Depressed older adults have poorer 
functional status28 and utilize more health care than non-depressed older adults.29 Older-
adults are also at increased risk for suicide compared to the general population, and 
depression is a major cause of  suicide.5 Primary care physicians are more likely to treat a 
patients’ physical symptoms rather than mental or emotional problems30 despite the fact that 
effective treatments for depression exist.14 Crucially, both older adults and persons with 
depression have higher rates of  multiple chronic conditions than the general population.12,31 
Patients presenting with multiple chronic conditions may be less likely to be screened or 
treated for mental health problems, due to providers’ prioritizing physical symptoms ahead 
of  mental or emotional ones.  
Patient-reported process of  care measures, such as adherence to screening guidelines, 
are increasingly being collected through electronic health records(EHRs).32 Use of  EHR data 
allows important variations in screening practices to be identified.  For example, are patients 
screened more often at one site instead of  another?  Are patients with multiple chronic 
conditions screened for depression more often?  Since the health status of  older adults is 
heterogeneous, understanding who is screened can illuminate inequities in the provision of  
care and identify opportunities for quality improvement interventions aimed at improving 
both care processes and outcomes.    
Understanding the impact of  measuring quality of  care using a patient-reported 
depression screening tool during this time of  expanding health care and limited primary care 
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providers is vital,33 especially when evidence for depression screening is mixed34 and 
Medicare is paying physicians to screen for depression annually during Annual Wellness 
Visits (AWVs).21  The primary objectives of  this study are to: 1) evaluate whether having an 
AWV is associated with the use of  screening, after adjusting for patient factors and 
clustering at the physician and clinic level; 2) delineate whether depression screening is 
conducted differently than other preventive care screenings (e.g. smoking status screening); 
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Impact of  Medicare Annual Wellness Visits on Depression Screening 
Abstract 
Importance: Medicare is promoting depression screening through their Annual Wellness 
Visit (AWV) benefit for Part B beneficiaries.  It is known that there are barriers to 
depression screening in primary care, but it is unknown how this new benefit affects 
depression screening. 
Objective: To assess whether having an AWV is associated with increased odds of  
depression screening, after adjusting for patient factors and clustering at the physician and 
clinic level. 
Design: Cross-sectional analysis of  retrospectively collected electronic health record data 
from October, 2010-August, 2012.   
Setting: Data was collected from 198 primary care physicians in 34 clinics.   
Participants:  Participants were Medicare patients 65 years or older who had at least one 
primary care visit during the study period.  Quota-random sampling was used so that half  
had an AWV index visit and half  had a non-AWV primary care index visit during the study 
period. 
Intervention: Having an AWV index visit versus having a primary care index visit. 
Main Outcome: Depression screen during patients’ index visit. 
Results: Depression screening during the index visit was low with 15% of  non-AWV patients 
screened and 10% of  AWV patients screened.  After accounting for physician and site 
clustering, AWV patients were not more likely to receive depression screening at a 
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statistically significant level (OR 1.33 95%CI:0.88-2.00).  Intraclass correlation for within 
clinician depression screening was strong, at 0.83.  There was a clear site effect of  screening 
with one site screening 78% of  AWV patients and 83% of  non-AWV patients, and six sites 
screening none of  their patients 
Conclusions: This study found that overall, depression screening during patient’s index AWV 
was uncommon (10%).  After adjusting for patient factors and clustering at the clinician and 
site level, the odds of  depression screening were not significantly different between patients 
who received an AWV visit and those who did not.  Our work shows that requiring 
depression screening as part of  a Medicare benefit is not a strong enough incentive to 
increase screening.  Future work that aims to increase depression screening should assess 




 Depression is one of  the most prevalent mental health diseases, affecting 1 in 6 older 
adults in the United States.1  Depressed older adults tend to have poorer functional status2 
and utilize more health care than non-depressed older adults.3  Furthermore, older adults are 
at increased risk for suicide compared to the middle-aged adults, and depression is a major 
contributing factor.4  Primary care clinicians are more likely to treat their patients’ physical 
symptoms rather than their mental or emotional problems.5  This is particularly relevant 
since depression is known to co-occur with other diseases,6  and older adults with depression 
often have multiple other chronic conditions.7,8 Therefore, patients at highest risk for 
depression may have numerous health concerns competing for clinicians’ time and attention. 
 A recent qualitative study of  outpatient clinicians found that there may be systematic 
under-use of  depression screening due the viewpoint that assessment and management of   
physical health problems should take precedence over depression screening, as well as 
concerns about follow-up care for patients who screen positive for depression.9   Further, 
there is mixed guidance on the importance of  routinely screening for depression in primary 
care,10,11 and it is uncertain whether depression screening alone improves outcomes.12  This 
vacillation in the literature may result in clinician’s screening based on their attitudes towards 
depression screening.13  Previous work has found that office organization and prevention 
delivery attitudes were associated with higher rates of  delivery of  U.S. Preventive Service 
Task Force recommendations;14 and, routine depression screening with sufficient staff  
supports was recommended in 2009 by the U.S. Preventive Service Task Force.10 
 In 2011, depression screening was incorporated as a required component in a 
patient’s initial Medicare’s Annual Wellness Visit (AWV).  The purpose of  the AWV is to 
allow time to “develop or update a personalized prevention plan.”15  AWV visits are 
reimbursed at a higher revenue-value unit rate, which creates an incentive for a visit intended 
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to include depression screening.16  This provides a unique opportunity to assess whether 
requiring depression screening during a preventive care visit increases depression screening 
compared to routine primary care visits.  The objective of  this study is to assess whether 
having an AWV is associated with increased odds of  depression screening, after adjusting for 




This is a cross-sectional study of  retrospectively collected electronic health record 
(EHR) data from 5,000 Medicare-covered patients across 198 physicians working in 34 
primary care practices in Maryland and Washington, D.C..  Physicians were Internal Medicine 
or Family Medicine specialists.  Quota-random sampling was used so that half  of  the 
patients had an AWV visit and half  of  the patients had a non-AWV primary care visit as 
their index visit.  A patient’s index visit was his/her visit identified between September, 
2010-August, 2012 which enabled the patient to be eligible for the study.  All patients had 
only one index visit, and this visit was used as the basis for the study analysis.  Of  the non-
AWV index visits, 48 percent were for chronic care, 32 percent for preventive care and 20 
percent for other reasons.  One hundred and forty-five individuals who had Welcome to 
Medicare visit on their index visit were excluded from the non-AWV index visit group since 
the Welcome to Medicare benefit includes preventive care screenings which are similar, but 
not the same, as the Annual Wellness Visit benefit.15  An additional 3 patients were excluded 
because their index visit clinician was a podiatrist or an acupuncturist, leaving a final sample 
size of  4,852 people.   
Data Collection 
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 Clinicians used General Electronic Health’s Centricity EHR system which was 
implemented in 2007.  This EHR system was designed for ambulatory office settings and 
can interface with practice management systems.  Data on the use of  the patient health 
questionnaire (PHQ), a validated patient-reported depression screening tool, was collected 
from structured observation fields in the EHR.  The template allowed clinicians to answer 
the first two questions (the PHQ-2), regarding Diagnostic and Statistical Manual’s (DSM-IV) 
two main symptoms of  major depression (i.e., depressed mood and anhedonia), and then if  
the patient answered positively to any one of  these questions, continued to the longer 
PHQ-9 template.  For clarity, the term PHQ-9 will be used to refer to both the PHQ-2 and 
PHQ-9 throughout this manuscript. 
Dependent Variable 
 The dependent variable was receiving a PHQ-9 screening during the patient’s index 
visit occurring between September 1, 2010 and August 31, 2012.   
Independent Variable 
 The type of  index visit, categorized as AWV-index versus non-AWV-index, was the 
independent variable of  interest.  Elements of  an AWV visit include acquiring the patient’s 
history through a health risk assessment, establishing medical/family history, and reviewing a 
patient’s risk factors for depression, including current or past experiences with depression.  
The AWV also includes assessment of  the patient’s height and weight, identifying the 
patient’s care team and detecting any cognitive impairments.  Finally, the clinician should 
counsel the patient through providing health advice and referrals as appropriate, determining 
a written schedule of  screenings and identify risk factors and conditions for which primary, 
secondary or tertiary interventions are recommended.16  AWV visits were defined by a code 
of  G0438 or G0439 in the EHR.17   
Covariates 
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 Patient-level covariates included demographics (age, race, sex) and the patient’s active 
diagnoses.  The interaction of  sex and age was included since older women are more likely to 
experience depression, but suicide is more prevalent among white males over the age of  
85.18 
 Diagnoses were obtained from the patient’s full problem list using ICD-9 code 
diagnosis, and determined to be active if  the diagnosis date was prior to the index date and 
either there was no stop date or the stop date was after the index date.  Four representative 
diagnoses known to be prevalent and strongly associated with depression were included in 
the analysis: cancer, diabetes, hypertension and Alzheimer’s dementia.  Hypertension, 
diabetes and cancer were included because of  their known relationship with depression 
among older adults.19,20  Alzheimer’s dementia was included since patients with dementia may 
have a decreased ability to answer patient-reported outcomes, such as the PHQ-9. 
 Multimorbidity (e.g. two or more chronic diseases) was also included as a covariate in 
the analyses since it has been shown to be associated with depression.21  Multimorbidity was 
defined by having 2 or more active diagnoses for common chronic conditions 
(hyperlipidemia, hypertension, rheumatoid arthritis, diabetes, ischemic heart disease, chronic 
kidney disease, depression, osteoporosis, chronic obstructive pulmonary disorder, cancer, 
asthma, atrial fibrillation, stroke, or heart failure).  All diagnoses were based on ICD-9 code 
definitions from the Medicare Chronic Conditions Data Warehouse.22   
Analysis 
 Multi-variable logistic regressions were used to examine the association of  index visit 
type with depression screening during the index visit.  A stepwise approach to analyses was 
adopted, in which patient-level variables were added to the model one by one to adjust for 
their potential confounding effects.  Clustered-hierarchical models as implemented in the 
STATA xtmelogit were used to take clustering at physician and clinic level into account.  An 
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identity covariance structure was used assuming that there was equal variances for all random 
effects at both the physician and site level.23  Output is reported in odd-ratios.  Between-
physician variance is reported for models that control for physician and site clustering. 
 Models were compared using AIC, BIC, and McFadden’s Adjusted R2 at the patient-
level and log-likelihood ratios at all levels.(Appendix)  Sensitivity analysis was conducted  
by rerunning the multivariable regressions with and without clustering at the physician level 
to assess the impact of  site 34 (the site with the highest screening rates) on odds of  
depression screening. All analyses were conducted using Stata 12.0. 
!
Results  
 Patients sampled were on average 72 years old, 61% were white, 61% were female 
and 48% had at least one AWV.  In total, 606 patients (12%) had a depression screen on 
their index visit.  Receipt of  depression screening on the index visit did not differ by sex.  
However, blacks, and adults with a non-AWV index visit were significantly more likely to be 
screened for depression. (Table 1)  There was a pronounced differences in racial distribution 
across different sites.(Appendix)  In contingency table analyses, non-AWV index patients had 
significantly more depression screening than AWV-index patients (15% vs. 10%; p<0.01).
(Table 1) 
Multivariable  logistic regression analyses 
 The regression that controlled for age, sex, and race had the best fit with the smallest 
AIC and BIC on the patient (first) level.24  The addition of  covariates was compared using 
likelihood-ratio tests post-estimation.  Adding health status variables did not improve the fit 
of  the model. (Not shown.) 
 In a multivariable logistic regression not accounting for clustering by clinician, the 
odds of  depression screening on the index visit changed with the inclusion of  patient-level 
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covariates.  Specifically, after controlling for race, age, and sex, the odds of  depression 
screening during an AWV visit changed from 0.62 to 1.19.  Additionally, blacks had 
significantly higher odds of  depression screening compared to whites in the multivariable 
model without adjusting for clustering (OR: 6.12; 95%CI:5.01, 7.50). 
 After accounting for clustering at the clinician level, AWV-index patients were no 
more likely to receive depression screening, compared to non-AWV index patients, at a 
statistically significant level in either the bivariate or the multivariable model(OR 1.28 
95%CI:0.86-1.94; OR 1.33 95%CI:0.88-2.00, respectively).  Additionally, the racial difference 
in screening disappeared after adjusting for clinician clustering.  The intraclass correlation, 
which is a measure of  within-clinician screening practices, was very strong (0.83) indicating 
the need for multilevel models.  Further, the odds of  depression screening for patients with 
an AWV-index visit compared to a non-AWV index after controlling for age, sex and race 
varied by 18% between clinicians.(Table 2) 
  Site factors accounted for part of  the variance in depression screening observed 
between physicians.  Adjusting for site correlation decreased within physician intraclass 
correlation from approximately 0.85 to 0.45.  The association of  patient-level confounders 
were similar regardless of  whether clinician only or clinic site and clinician clustering were 
accounted for in the model. The average odds of  depression screening for patients with an 
AWV-index visit compared to a non-AWV index decreased to 11% between clinicians once 
site clustering was account for in the model.(Table 2) 
Percent of  Depression Screens by Visit Type for Sites 
 The percent of  depression screens by visit type was broken down by site for sites 
that had more than 100 patients (Figure).  There was a clear site effect of  depression 
screening with site 34 screening 78% of  AWV-index patients and 83% of  non-AWV index 
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patients.  Six sites screened none of  their AWV-index patients or their non-AWV index 
patients. 
Sensitivity Analysis 
 The results of  the sensitivity analysis found that site 34 had a important impact on 
the overall odds of  depression screening.  When only site 34 was analyzed, the odds of  
depression screening was 44% lower for patients with an AWV index visit compared to a 
non-AWV index visit controlling for age, sex and race.  However, when site 34 was excluded 
from the analysis, patients with an AWV index visit had 4-fold greater odds of  depression 




 This study found that overall, depression screening during patient’s AWV was low 
(10%).  In the bivariate regression modeling the relationship between depression screening 
and index visit type, patients with a non-AWV index visit were 38% more likely to be 
screened for depression than AWV index patients. After adjusting for patient factors and 
clustering at the clinician and site level, the odds of  depression screening were not 
significantly different between patients who had an AWV visit and patients who had a 
primary care visit. Screening for depression screening during a preventive care visit was 
strongly associated with clinician and practice site.  Without accounting for these additional 
clustering factors, patient-level determiners such as race would have appeared highly 
associated with the odds of  depression screening.  Further, the best fitting model did not 
include patient health factors such multimorbidity, cancer, diabetes, hypertension or 
dementia. 
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Surprisingly, we found a very prominent clinician and site effect of  screening, despite 
the AWV benefit.  One site screened 78-83% of  patients during their index visit 
indiscriminately of  whether the visit was an AWV or primary care visit, and six sites screened 
none of  their patients.  In the regression models, the intraclass correlation, was very strong 
(0.83) implying a clinician provided the same level of  screening for all patients.  These results 
suggest that simply providing patients with the opportunity to receive mental health 
preventive care through the AWV benefit is not sufficient for that care to occur.  The 
sensitivity analysis found that the AWV benefit significantly increased the odds of  
depression screening among sites that had lower overall screening rates. However, as seen in 
the figure, this effect was not uniform across all sites with seven sites not screening any 
AWV-index patients for depression.  Policy initiatives interested in increasing depression 
screening equably among clinics should consider how the benefit will be implemented.   
Medicare’s AWV benefit began in January, 2011 with the goal to increase access to 
preventive care.  The AWV was not intended to replace patients’ yearly physical, but instead 
to provide time to discuss new or chronic medical conditions.25  Depression screening is 
explicitly included as an essential task during a patient’s initial AWV visit.  Since our study 
took place in 2011 and 2012, and patients cannot have two AWVs within 12 months of  each 
other, we are confident that our sample includes patient’s initial AWV visit.  Other tasks 
included as part of  the AWV are: taking patient’s history through a health risk assessment, 
establishing medical/family history, taking patient’s height and weight, identifying the 
patient’s clinicians and detecting any cognitive impairments.  Clinicians may be prioritizing 
other tasks over depression screening, especially since previous work has found that 
clinicians have been cautious about the validity of  depression screening tools and prefer 
clinical judgement in determining whether a patient has depression.26 
!16
 The U.S. Preventive Service Task force recommends depression screening only when 
“staff-assisted depression care supports are in place”; yet, staff-assisted depression supports 
can be as minor as having a nurse notify the physicians of  the patient’s score.10  Conversely, 
the Canadian Task Force on Preventive Health Care did not recommend routine depression 
screening for adults.11   A systematic review found that screening for depression in older 
adults without “substantial staff-assisted depression care supports” is not likely to improve 
depression outcomes.27  This mixed-evidence, plus the need for sufficient depression 
screening supports, may explain the substantial site difference in screening.   Indeed, a 
qualitative study found that clinicians reported concern about both how to screen for 
depression, and the lack of  options available if  a patient were diagnosed with depression.28 
 As shown in our figure, one practice site was the main contributor to depression 
screens, regardless of  whether the patient had an AWV-index visit or not.  Previous studies 
on variation in the delivery of  health care have shown that variation in care is not indicative 
of  higher quality care.29,30  Physicians face competing priorities when deciding which services 
to recommend to patients including patients’ health care needs, organizational and financial 
barriers and facilitators, and mixed evidence regarding the effectiveness of  care.29  Recent 
work on clinic predictors of  adopting a depression care improvement model in Veterans’ 
Affairs found that sites with poor communication among staff, fewer quality improvement 
processes, insufficient financial resources, and no psychologist or psychiatrists on staff  had a 
40%-62% reduced odds of  adopting a depression care improvement model.31 
 There are several limitations to our study.  We conducted a cross-sectional analysis, 
and therefore no comments regarding causation can be made.  Further, none of  the models 
fit especially well on the patient level, even when including patient health factors, such as 
multimorbidity status.  There were very clearly clinician and site level factors, which we could 
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only account for using clustering in our models.  Notably, our ability to account for 
clustering within both clinicians and sites is a major strength of  this work.  Finally, our study 
occurred during the first 20 months of  the AWV benefit and depression screening during 
the AWV may have increased since that time. 
!
Conclusion 
 Our work shows that requiring screening as part of  a Medicare benefit is not a 
strong enough incentive to overcome barriers to depression screening that were not 
addressed through clinic practice style.  Further work should be done to identify which 
practice characteristics promote appropriate depression screening, and facilitate compliance 
with Medicare’s AWV.  There should also be evaluations on barriers to depression screening 
during patient’s AWV.  We need to have a better understanding whether depression screening 
has value for patients in this context, and if  patients and clinicians find other activities more 
valuable.  Finally, when designing interventions to increase screening for specific patient 
groups, patterns of  care should be carefully evaluated first, including variations in care 
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*Defined by ICD-9 diagnosis code in the EHR !
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2344 (48) 231  (10) 375 (15) <0.001




Figure 1. Percent of  Depression Screens Stratified by Index Visit Type and Site 
*Sites with ≥100 patients are presented individually.  Sites with <100 patients are grouped 











#The physician variance is 18.1%, 95%CI: 11.0, 29.7.  The intraclass correlation is 0.85, 
95%CI:0.77, 0.90.  
The physician variance is 11.3%, 95%CI: 2.5, 50.0; the site variance is 11.3%, 95%CI: 2.0, 
64.6.  The intraclass correlation for physician is 0.44 (95%CI:0.05, 0.91) and site is 0.87, 
95%CI:0.78, 0.93).  
‡  Model includes sex, age, and race 
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Table 2. Odds of Depression Screening During the Index Visit
No Clustering Physician-Level Clustering# Physician and Site 
Clustering

























Age ≥ 75 years 





































 *p-value ≤0.05 
**p-value ≤0.01 
 The physician variance is 1.0%, 95%CI: 0.3, 3.4.   
 The physician variance is 8.5%, 95%CI: 4.4, 16.4. 
‡  Model includes sex, age, and race 
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Table 3. Sensitivity Analysis: Odds of Depression Screening During the Index Visit with and 
without Site 34
No Clustering Physician-Level Clustering
Model Only site 34‡  
AOR
Excluding site 34‡  
AOR
Only site 34‡   
AOR 




0.75 (0.49, 1.13) 1.20 (0.80, 1.81) 0.56* (0.32, 0.97) 4.06** (2.09, 7.90)
 Female  
(ref =male)
1.16 (0.76, 1.76) 1.10 (0.74, 1.64) 1.12 (0.72, 1.75) 1.60 (0.96, 1.65)
Age ≥ 75 years 
(ref =  <75 years)
1.48 (0.96, 2.26) 1.34 (0.91, 1.98) 1.53 (0.97, 2.39) 1.00 (0.61, 1.62)
Black race 
(ref= White)
1.18 (0.71, 1.96) 0.54* (0.31, 0.95) 0.91 (0.51, 1.65) 0.96, (0.49, 1.89)
Other race 
(ref = White)
0.42 (0.09, 1.90) 0.15 (0.02, 1.06) 0.39 (0.07, 2.05) 0.18 (0.02, 1.42)
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Depression screening in primary care: either with smoking-screening or not at all  
Abstract 
Background: Depression is a highly prevalent disease, for which there may be systematic 
under-use of  screening due to different barriers for depression screening than other physical 
health screenings.  
!
Objective: To delineate whether depression screening is conducted differently than other 
preventive care screenings (e.g. smoking status screening).  Specifically, this analysis will 
identify: 1) the difference in frequency in which patients are screened for smoking versus 
depression screening; and 2) the association between patient-level and clinic factors and 
receipt of  both screenings. 
 
Methods: Secondary analysis of  retrospectively collected electronic health record (EHR) data 
from 4,763 Medicare-patients in 34 primary care practices between 2010-2012.  The 
relationship between three independent variables (e.g. having multimorbidity, history of  
stroke, and/or having depression) and receipt of  depression and smoking screening was 
evaluated. Multilevel logistic regressions were conducted cross-sectionally for each 
independent variable at the patient’s first visit.  Longitudinal analysis was conducted using 
patients’ first five visits in the study to obtain an estimate of  the odds of  screening over 
time. 
!
Results: Fifty-percent of  the patients were screened for smoking use at every visit but not 
depression (n=2378).  Only one person was screened for depression and not smoking status. 
In the adjusted longitudinal analyses, having multimorbidity was associated with decreased 
odds of  receiving both depression and smoking status screenings, compared to either 
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smoking status screening or no screen, by 28% after adjusting for race, age, and sex.(AOR: 
0.72, 95%CI:0.52-1.0).  The odds of  receiving both screens, compared to either smoking 
status screenings or no screen, was not significant for patients with history of  stroke or 
depression in the multivariable-adjusted analyses. 
!
Conclusions: We found a consistent pattern of  concurrent depression and smoking-
screening.  Additionally, we found that patients with multimorbidity had decreased odds of  
receiving both depression and smoking-status screening in the multivariable regression.  This 
finding is not surprising given barriers found in earlier studies for depression screening, 
which may be amplified for patients with multimorbidity.  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Introduction: 
Depression is one of  the most prevalent mental health diseases, affecting 1 in 6 older  
adults in the United States.1,2  Medicare reimbursement for annual depression screening in 
primary care started in 2011.3  A recent review found that 10% of  patients in primary care 
may meet the criteria for major depressive disorder.4  Yet, screening for depression is 
considered inadequate by many experts,4 despite availability of  validated tools for depression 
screening.5  In order to increase depression screening, quality incentives are being 
implemented as part of  Meaningful Use stage 2 (the second phase of  the Centers for 
Medicare & Medicaid Services’ incentive program for effective use of  electronic health 
records (EHR)) for screening for depression and subsequent documentation of  a clinical 
plan.6 
A recent qualitative study of  outpatient clinicians found that there may be a 
systematic under-use of  depression screening.7  Potential barriers from the clinicians’ 
viewpoint include the assumption that assessing physical health should be done first, and 
concerns regarding the availability of  follow-up care for patients who screen positive for 
depression.7  This is particularly relevant since depression is known to co-occur with other 
diseases,8 suggesting that the patients at highest risk for depression may have numerous 
health concerns competing for clinicians’ time.  For example, 16-40% of  stroke patients 
experienced minor or major depression after a stroke,9 which is much higher than base rates 
of  depression.10 
Receipt of  preventive care screenings, such as depression, may be a function of  how 
care is delivered in a particular clinic.  Factors that are associated with guideline-consistent 
screening by a physician include access to an EHR, younger age, seeing fewer patients per 
week, and having a patient who prefers screening.11   Particular clinicians and sites may 
conduct more preventive care screenings due to their structural capabilities.12  However, it is 
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not well understood whether care structure affects screenings for mental (e.g. depression) 
and physical health (e.g. smoking) equally. 
 Smoking-status screening is a patient-reported preventive care screening, similar to 
depression screening, but it occurs much more often.  As noted in HealthyPeople 2020 
objectives, smoking status screening occurred in 62 percent of  office-based ambulatory care 
setting visits in 200713 and only 2 percent of  physicians screened adults for depression in 
2007.14   Importantly, physicians may not be the individuals actually conducting the 
screening; instead, it may be a nurse or medical assistant’s responsibility.  
 Smoking status screening is a good comparator to depression screening.   Both are 
screens of  patient-reported outcomes.  Positive screens on either may be indicative of  a 
chronic condition that requires continued follow-up, and may require cognitive or behavioral 
therapy, and/or pharmacotherapy to achieve desired outcomes.15  Rates of  smoking and 
depression are similar in older adults.16,17  Both smoking screening and depression-screening 
have been recommended by the U.S. Preventive Services Task Force.18,19  However, the 
recommended follow-up for a positive screen is quite different--if  a smoking status screen is 
positive then the physician can conduct a “brief  counseling (3 minutes or less)”.18  If  a 
depression screen is positive, a full diagnostic interview should occur.19 
 The objective of  this study is to delineate whether depression screening is conducted 
differently than other preventive care screenings (e.g. smoking status screening).  Specifically, 
this analysis will identify: 1) the difference in frequency in which patients receive smoking, 
depression, or both screens; 2) the association between patient-level factors and receipt of  
one or both screenings; and 3) the impact of  clinic-level clustering on the association 
between patient-level factors and receipt of  screenings.   
It is hypothesized that depression screening may occur at a different frequency than 
smoking status screening, but to our knowledge, no study has empirically tested this 
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hypothesis.  Understanding whether clinicians screen for smoking-use and overlook 
depression screening, when given the opportunity for preventive-care screening, is key to 
knowing whether there is a disparity in willingness to identify mental health conditions, 




This is a secondary analysis of  retrospectively collected EHR data from 5,000 
Medicare-covered patients across 198 physicians working in 34 primary care practices in 
Maryland and Washington, D.C..  Physicians were Internal Medicine or Family Medicine 
specialists.  For the purposes of  the original study evaluating the Annual Wellness Visit 
(AWV), quota-random sampling was used so that half  of  the patients had at least one 
Annual Wellness Visit (AWV)19 and half  of  the patients had a non-AWV primary care visit 
during the study period.  In this analysis, patients’ probability of  being screened for 
depression and smoking status was compared to both the probability of  receiving neither 
screen and the probability of  only being screened for smoking status both cross-sectionally 
and longitudinally. 
Data Collection 
Clinicians within these practices used General Electronic Health’s Centricity EHR 
system which was implemented in 2007.  This EHR system was designed for ambulatory 
office settings and can interface with practice management systems.   
Since patients’ weight is routinely assessed at primary care visits, a body mass index 
(BMI) observation was used to mark whether a patient had a visit to any of  the primary care 
practices between September 1, 2010 and August 31, 2012.  BMI was collected from 
structured observation fields in the primary care practices’ EHR system.  BMI scores are 
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automatically calculated if  the patient’s height is in the EHR and the patient’s weight is taken 
during the visit.  Only the date of  each BMI observation was used in this analysis.  Five-
percent of  patients originally included in the study set (n=237) did not have any BMI score.  
These patients were excluded from the original population of  5,000 leaving a study 
population of  4,763 people. 
 Data on smoking screening also came from structured fields in the EHR.  The 
smoking screening variable was defined based on whether a patient’s smoking status was 
captured as a structured observation term (i.e., a checkbox) in the EHR.  Patients were asked 
if  they were a current smoker and their answer was recorded in the EHR in a structured 
form. 
 Depression screening was defined based on use of  the patient heath questionnaire 
(PHQ), a validated patient-reported depression screening tool5  specified for screening at the 
time of  this study, captured as structured observation fields in the EHR.  The template 
allowed clinicians or staff  to ask the first two questions (the PHQ-2), regarding Diagnostic 
and Statistical Manual’s (DSM-IV) two main symptoms of  major depression (i.e., depressed 
mood and anhedonia), and then if  the patient answered positively to one of  these questions, 
continued to the longer PHQ-9 template. 
Independent Variables 
 We selected three different types of  key independent variables for the analysis based 
on a review of  the literature, conceptual model of  factors affecting screening, and data 
availability.  The first variable is multimorbidity status, a marker for patient factors that could 
compete for time with screening for depression.  For the second variable, we chose one 
unrelated significant illness associated with higher rates of  depression which increases the 
importance of  depression screening, history of  stroke.  The third is history or active 
depression, which increases the importance of  screening. 
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We hypothesized that multimorbidity could be associated with higher or lower rates 
of  depression screening.  Multimorbidity is a risk factor for depression, which could increase 
the likelihood of  screening;21 yet, patients with multimorbidity may have competing interests 
for physicians’ time, lowering the likelihood of  depression screening.  Multimorbidity was 
defined by 2 or more active diagnoses for common chronic conditions (hyperlipidemia, 
hypertension, rheumatoid arthritis, diabetes, ischemic heart disease, chronic kidney disease, 
depression, osteoporosis, chronic obstructive pulmonary disorder, cancer, asthma, atrial 
fibrillation, stroke, or heart failure) based on the patient’s problem list.22  The ICD-9 codes 
for categorizing comorbidities were obtained from the Chronic Disease Warehouse.22 
Stroke was included as a second independent variable because after a stroke, a 
patient’s risk for depression is between 16-40 percent.9  Moreover, assessing the impact of  
screening for a single disease with a known risk for depression, compared to patients with 
multimorbidity, would reduce the heterogeneity of  the population who would be positively 
coded for this independent variable.  Individuals with a previous history of  stroke (ICD-9 
codes: 430, 431, 433.01, 433.11, 433.21, 433.31, 433.81, 433.91, 434.00, 434.01, 434.10, 
434.11, 434.90, 434.91, 435.0, 435.1, 435.3, 435.8, 435.9, 436, 997.02) were coded as “one”
and patients with no history or stroke were coded as “zero”.  
Finally, physicians may screen for depression only if  they already suspect depression, 
or to use as a way to assess depression remission.  Therefore, depression status is being 
included as an independent variable with patients who have an active diagnosis of  
depression or previous diagnosis of  depression with the problem list (ICD-9 codes 296.20, 
296.21, 296.22, 296.23, 296.24, 296.25, 296.26, 296.30, 296.31, 296.32, 296.33, 296.34, 
296.35, 296.36, 296.51, 296.52, 296.53, 296.54, 296.55, 296.56, 296.60, 296.61, 296.62, 
296.63, 296.64, 296.65, 296.66, 296.89, 298.0, 300.4, 309.1, 311) coded as “one”.  All others 
will be coded as “zero”.  
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Dependent Variables 
 Screening status on each visit is the dependent variable.  The visit date is based on 
having structured BMI observation for which smoking and depressions screens were 
matched by date.  Cross-sectional analysis was conducted for the first visit since every patient 
had at least one visit.  Longitudinal analysis, which allows for clustering by physician and site, 
was conducted for patients’ first five visits.  
 For the cross-sectional analysis, each patient’s first visit was defined as no-screen (e.g. 
neither a smoking or a depression screen on the date of  the BMI observation); smoking 
screen only (e.g. a smoking screen on the same date as the BMI observation, but no 
depression screen); or both-screens (e.g. smoking and depression screen on the same date as 
the BMI observation).  Only one patient had a depression screen without a smoking screen.  
Due to this small sample, receipt of  a depression screen without a smoking status screen was 
not created as a dependent variable.    
 For the longitudinal analysis, the dependent variable was reported two ways.  First, as 
the odds of  having both a depression and smoking status screening versus having neither 
screen or only a smoking status screen.  Second, as the odds of  having both a depression 
and smoking status screening versus having only a smoking status screen.  For each patient’s 
first five visits, the visit was coded 1 if  the patient received both screens and 0 otherwise.  
The benefit of  longitudinal analysis is it accounts for the possibility a patient received both 
screens on a later visit, thereby limiting the possibility that the patient’s initial visit was not an 
opportunity for screening.  Previous work has demonstrated that taking into account at least 
four visits provides stable estimates of  preventive care screening.23  
Covariates 
!32
Patient-level demographic variables (age, race, sex) were included as covariates in the 
adjusted models.  Age was included as a continuous variable.  Race was included as a 
categorical variable with white being the reference group compared to black or other race.  
Analysis 
For each visit, the percent of  patients who had no screen at that visit, either a 
smoking screen or a depression screen, or both screens was reported for up to the patient’s 
15th visit. For patients who had only 1 visit, only 2 visits, only 3 visits, only 4 visits, or 
greater than or equal to 5 visits, the number of  screens per visit up to five visits was also 
reported to provide a description of  how having more opportunities for screening affects 
the number and type of  screens at each visit.  Fisher’s exact test was used to compare receipt 
of  screening on the first visit for people who had less that 5 visits compared to patients with 
equal to or greater than 5 visits.  
Multilevel logistic regressions were run for the cross-sectional analysis to identify the 
effect of  each independent variable (multimorbidity, history of  stroke and history of  
depression) on the odds of  screening during the first visit.  Five logistic models were run for 
each independent variable: no screening versus any screening; no screening versus both 
smoking and depression screening; smoking screening alone versus no screening; smoking 
screening alone versus both smoking and depression screening; and no screening or smoking 
screening alone versus both smoking and depression screening. Site clustering was accounted 
for using hierarchical models since there is a effect of  clinic site on screening practices.
(Figure 1) Output for all models is reported both as unadjusted and adjusted (for age, race 
and sex) odds-ratios.    
Six longitudinal logistic regressions were conducted using each of  the independent 
variables: multimorbidity, history of  stroke and history of  depression.  Longitudinal analysis 
allowed assessment of  whether the odds of  having both smoking and depression screening 
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compared to the odds of  having either no screen or only a smoking screen was impacted by 
the number visits.  A second analysis compared the odds of having both smoking and 
depression screening compared to the odds of  having smoking screening alone.  
Longitudinal analysis allows for a more stable estimate of  patient’s odds of  screening since 
more than one visit is included in the analysis.   Further, conducting both sets of  regressions 
allows an evaluation of  the impact of  excluding patients with no screening from the analysis.  
The longitudinal analysis included screens during a patient’s first 5 visits in the study.  Age, 
sex and race were included as covariates in all of  the regressions.  Standard errors for all 
regressions were clustered by patient and clinic site using multilevel modeling. 
 Stata 12.0 was used to conduct all analysis.  Institutional review board approval was 
received from Johns Hopkins Bloomberg School of  Public Health Review Board.  
!
Results 
 The majority of  patients in the study were white (63%; n=3,002) and the mean age 
was 74 years.  The number of  visits ranged from only one visit (n=579 people) to thirty 
visits (n=6 people), with the overall average number of  visits being 5 (SD: 3.4).  In total, 581 
patients only had 1 visit; 672 only had 2 visits; 585 only had 3 visits; 570 only had 4 visits; 
and 2,351 patients had 5 or more visits. 
 Almost all patients were screened for smoking or depression during at least one visit.  
When looking at the extremes, eighty-nine individuals (2%) were never screened for smoking 
or depression and 226 individuals (5%) were always screened.  Fifty-percent of  the patients 
were screened for smoking use at every visit but not depression (n=2,378).  Only one person 
was screened for depression and not smoking status.  Table 1 presents the demographic 
characteristics of  the population by overall proportion of  screens.   
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As seen in figure 2, the majority of  individuals were screened only for smoking 
during any given visit.  There was a statistically significant difference in the number of  
screens received on the first visit by patients with less than 5 visits compared to patients with 
greater than or equal to 5 visits (p<0.01).  Further, 12% of  patients with at least five visits 
received both depression and smoking-status screens on each of  their first five visits.  In 
comparison, 5% of  patients with four visits received a depression and smoking-status screen 
on each of  their four visits.  
Presented in figure 1 is the percentage of  depression and smoking screens for each 
visit by site.  There is a site effect with site 34 screening the majority of  their patients 
(~87%) for both depression and smoking-status at each visit.  Conversely, site 25 screens 
93% of  patients for smoking alone on the first visit; and 53% of  patients for smoking alone 
on their second visit. Patients are not screened for depression during either visit. 
Cross-sectional analysis 
The adjusted and unadjusted odds of  screening during the first visit, after accounting 
for clinic-level clustering, was determined.  Adjusting for age, race and sex did not impact 
the odds considerably for any comparison.  Patients with depression had significantly lower 
odds of  receiving both a depression and smoking status screen compared to receiving no 
screening, after adjusting for age, race and sex (AOR: 0.44, 95%CI:0.23-0.93).  Patients with 
a history of  stroke had significantly higher odds of  receiving a smoking status screening 
compared to no screening, after adjusting for age, race and sex (AOR: 1.58, 95%CI:
1.09-2.28).  However, patients with stroke had lower odds of  receiving any screening (either 
smoking screening alone or both smoking and depression screening) compared to no 
screening after adjusting for age, sex, and race(AOR:0.63, 95%CI:0.44-0.91).  Having 
multimorbidity did not change the odds of  screening for any comparison. (Table 2) 
Longitudinal analyses 
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 In the adjusted longitudinal analyses, having multimorbidity was associated with 
decreased odds of  receiving both depression and smoking status screenings compared to 
either smoking status screenings or no screening by 28% after adjusting for race, age, and 
sex.(AOR: 0.72, 95%CI:0.52-1.0).   The odds of  receiving both screens, compared to either 
smoking status screenings or no screen, was not significant for patients with history of  
stroke or depression in the multivariable-adjusted analyses. 
 Approximately 3% (95%CI:1.9-4.3) of  the variance in the screening was attributable 
to differences across patients, and 12% (95%CI:8.4-16.7) was attributable to differences 
across sites for patients with a history of  stroke.  However, the variance among sites was 
smaller when calculating the odds of  receiving both screens compared to no screen or 
smoking status screening only for patients with depression compared to patients without 
depression (3%, 95%CI: 2.0-4.3 between patients and 5%, 95%CI:3.8-7.1 between sites).
(Table 3) 
 There was no change in odds of  being screened for both depression and smoking 
status compared to being screened for smoking alone for patients with multimorbidity, 
depression, or history of  stroke.(Table 3) 
!
Discussion 
 In our analysis, we found that a majority of  patients were screened for smoking 
status at every visit, but very few patients were being screened for depression, and almost 
none were screened for depression alone.  Depression screening was occurring concurrently 
with smoking status screening, and this pattern was stronger among patients with greater 
numbers of  visits in the study.  In the cross-sectional multilevel logistic analysis, adjusting for 
age, sex, and race did not greatly impact the odds of  screening for any of  the outcomes.  
Patients with a history of  stroke had significantly higher odds of  receiving no screening 
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compared to receiving any screening (e.g. both smoking and depression screening or 
smoking alone) (AOR: 0.63) after adjusting for age, sex, and race.  Of  note, patients with 
depression had 66% higher odds of  receiving no screening compared to receiving both 
depression and smoking screening (AOR:0.44) Neither having multimorbidity, nor history of  
stroke, significantly increased the odds of  receiving both depression and smoking screening 
compared to either no screening or smoking screening alone on the first visit. 
 In longitudinal model accounting for clustering within patient and site, the impact of  
having a history of  stroke or depression on the odds of  receiving screening was eliminated.  
Interestingly, the odds of  patients with multimorbidity receiving neither screen or only a 
smoking status screen compared to both screens was 18% higher (AOR: 0.72; 95%CI: 0.52, 
1.0).  While this finding was barely significant, patients with multimorbidity may experience  
more intractable barriers to depression screening over time.  
 Conducting multiple preventive-care screenings at the same time, such as during an 
annual exam, is advocated as a good way to provide health care.  Annual physical exams, 
which are an ideal time for concurrent preventive-care screenings, improve both patient-
physician relationships and detection of  subclinical illness.24  Our study found a strong 
presence of  concurrent screening for smoking status and depression, suggesting that 
depression screening often occurs along with smoking status screening.  Yet, it may be 
difficult for physicians to administer all of  the guideline-recommended preventive care 
screening due to time constraints, concern about harms associated with care, and patient 
preferences, especially for patients with multimorbidity.25  Depression screening may 
strengthen these concerns due to stigma associated with depression diagnoses for patients,26 
concerns about the impact of  screening on the patient-physician relationship,26 and the 
considerable time required in follow-up if  a depression screen is positive.19  Especially since 
there is good evidence for the positive effects of  3-minute counseling for tobacco-users,18 
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and there is no short intervention for patients with depression that has been shown to 
improve outcomes. 
 Patients who accessed care more often were screened with greater frequency for 
both depression and smoking status.  Nearly 90% of  patients were screened for smoking 
during any given visit in the study, which may have been a result of  initiatives to screen for 
smoking at every visit.27,28  Screening for depression at every visit may be inefficient care, but 
never screening for depression is not optimal either.  Especially for patients with 
multimorbidity, since depression commonly occurs alongside other chronic diseases.29  
Solutions for screening at timely intervals may involve clinical decision support for 
preventive care screening; though, a more comprehensive intervention than implementing an 
EHR may be required to improve care quality.30  The strong site effect is suggestive that site-
specific workflow is a major factor in how often preventive screening occurs. 
 Other studies have found that quality of  care measures for depression may have 
different facilitators than measures for physical health.  For example, Friedberg and 
colleagues found that none of  the structural capabilities measured among primary care 
practices (patient assistance, EHRs, a culture of  quality, or enhanced access) were associated 
with increased HEDIS depression quality measure completion rates, but they were 
associated with measures of  physical health care.12  On-site language interpreters were the 
exception which significantly increased the adjusted probability of  completion of  the 
HEDIS depression quality measure.12       
 Our paper has several limitations.  Our study only assessed screening in Medicare 
patients in 34 practices across one state, limiting the generalizability of  this study.  Further, 
we assessed the likelihood of  depression screening for patients with multimorbidity, stroke, 
and depression.  The likelihood of  depression screening may be different for different 
populations of  patients.  Finally, this was a retrospective analysis, and not all patients had the 
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same number of  visits within the study period.  Therefore, there is risk of  bias that the 
patients who had less visits may have had less opportunity for depression screening.  We 
attempted to control for this in the analysis by comparing depression screening to smoking 
status screening with the assumption that screening for smoking status and depression 
should be similar since the prevalence of  depression is similar, or greater than smoking 
status among older adults.16,17  Finally, we are unable to determine how the depression or 
smoking status screen was administered in the clinics.  
!
Conclusion 
While differences in depression and smoking status screening were anticipated, the 
consistent pattern of  concurrent depression and smoking-screening was not.  We found that 
depression screening is rarely conducted in isolation.  Patients with multimorbidity had 
decreased odds of  receiving both depression screening and smoking-screening in the 
adjusted longitudinal regression which accounted for patient and site clustering.  This finding 
is not surprising given barriers found in earlier studies for depression screening, which may 
be amplified for patients with multimorbidity.25,26   Variation in depression screening by site 
may be due to lack of  clear guidelines on when to screen for depression resulting in an 
“often” or “never” approach by clinics.  Clinic proclivity for preventive-care screening clearly 
impacted how often a patient was screened.  The efficiency of  different clinic workflows for 
preventive-care screening should be considered especially when trying to meet depression 
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Table 1. Demographic Characteristics by overall proportion of  screenings
 Patients with no 
screenings always 
(n=89) (%)
Patients with only 
smoking screening 
(n=2378) (%)
Patients with both 
screening always 
(n=226) (%)
Patients with mix 




Mean age 75 (7.4; 64-90) 73 (6.8; 63-98) 74.4 (7.2; 63-94) 74 (6.9; 63-96)


















59 (66) 1403 (59) 158 (70) 1527 (74)
Stroke = yes 7 (8) 113 (5) 8 (4) 151 (7)
Depression = yes 11 (12) 295 (12) 25 (11) 337 (16)
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Figure 1. Percent of  screening for depression and smoking by clinic site* for visits 1-4.   
Key: 0 = no screening during that visit; 1 = only smoking screening during that visit; 2= 
both smoking and depression screening during that visit. 








Table 2. Cross-sectional analysis: Impact of  Multimorbidity, History of  Stroke and Depression on 
receipt of  smoking and depression screening when accounting for site clustering
Unadjusted Model Adjusted for Age, 
Race & Sex










Smoking screening alone or both 
depression and smoking screening 






Both depression and smoking screening 
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Both depression and smoking screening  






History of  
stroke
Smoking screening alone or both 
depression and smoking screening 






Both depression and smoking screening 













Both depression and smoking screening 






Both depression and smoking screening  








Smoking screening alone or both 
depression and smoking screening 






Both depression and smoking screening 













Both depression and smoking screening 






Both depression and smoking screening  








N’s: Sample size for each comparison varies. No screening versus any screening n=4734; No 
screening versus both screens n= 1099; Smoking screening alone versus no screening n= 
4109; Smoking screening versus both screening n= 4260; No screening or smoking 




*Adjusted for Sex, Age, Race, and clustering within patient and clinic site !!
Table 3. Longitudinal analysis: Impact of  Multimorbidity, History of  Stroke and Depression on 
receipt of  smoking and depression screening
Predictor Outcome Odds* 95%CI P-value
Having multimorbidity Odds of  having both screens 
(ref  = neither screen or smoking)
0.72 0.52 -1.0 0.05
Odds of  having both screens  
(ref  = smoking screen only)
0.82 0.57-1.18 0.280
History of  stroke Odds of  having both screens 
(ref  = neither screen or smoking)
1.16 0.68-1.97 0.58
Odds of  having both screens  
(ref  = smoking screen only)
1.20 0.66-2.18 0.552
Having depression Odds of  having both screens 
(ref  = neither screen or smoking)
0.73 0.49-1.08 0.12
Odds of  having both screens  
(ref  = smoking screen only)
0.73 0.47-1.13 0.161
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Depression Process of  Care Completion Rates Among Medicare Part B Beneficiaries 
Abstract 
Background: Depression, a common mental health condition, often remains underdiagnosed 
and undertreated.  New quality indicators are being developed to increase identification and 
appropriate management of  depression in primary care. 
!
Objective: To identify the prevalence and correlates of  depression screening associated with 
quality measures and patient correlates of  meeting quality indicators. 
!
Methods: Secondary-analysis of  retrospectively collected electronic health record data for 
5,000 Medicare patients.  Quality of  depression care measures were identified in 2013 using 
databases which have a rigorous process of  reviewing measures.  Seven measures were found 
for which all the necessary information was available to compile that quality measure: general 
screening; depression management; depression reassessment; screening after stroke; 
screening after heart disease; depression reduction; and, depression remission.  Assessment 
of  completion of  the seven quality indicators was determined based on the denominator and 
numerator specifications of  each measure. Bivariate and multivariable logistic regression 
analysis was used to determine the predictors of  meeting quality indicators based on patient’s 
age, sex, race and whether he/she had an Annual Wellness Visit(AWV).  Standard errors in 
the regressions were clustered by physician or site. 
!
Results: Screening for depression among Medicare patients was low, at 17%.  Performance 
on quality measures was generally low, varying from 10% for the screening for depression 
reduction measure to 77% for the depression remission at 12 months measure. In the 
multivariable model, controlling for clustering, patients older than 75 years were 41% more 
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likely to meet the general depression screening measure (AOR:1.41; 95%CI: 1.05-1.90). 
Patients with an AWV compared to patients without an AWV had an adjusted odds ratio of  
3.93 for meeting the depression reduction measure after accounting for age, race, sex and 
site clustering (95%CI: 1.46-10.57). 
!
Conclusions: Only a small proportion of  Medicare patients received the recommended 
screening and follow-up care needed to meet the quality measures for depression monitoring 
and follow-up. There was no consistent patient characteristic that was correlated with 
screening on all measures.  Further evaluation and validation of  measures of  depression care 
quality should be conducted before these measures are implemented widely. 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Introduction 
 Depression is a common mental health condition that is a major cause of  total years-
lived with disability world-wide.1-4 Nevertheless, depression often remains underdiagnosed 
and undertreated. Depressed older adults have poorer functional status5 and utilize more 
health care than non-depressed older adults.6 Older-adults are also at increased risk for 
suicide compared to the general population, an adverse outcome that is mainly attributable 
to depression.7  The costs and disability associated with depression makes identifying patients 
with this illness and providing appropriate treatment an important goal.  Older adults are 
often treated for depression in primary care as opposed to speciality care.4  Indeed, in 2011, 
Medicare initiated coverage of  one depression screen per year for Part B beneficiaries as part 
of  the Annual Wellness Visit.8 
 Depression screening in primary care is currently being incorporated as quality of  
care indicator through different policy initiatives.9-12  Through quality indicators, physicians 
are being asked to screen various types of  patients for depression, including the general 
population,11 patients previously diagnosed with depression to monitor symptoms,14 and 
patients at higher risk for depression (e.g. patients with a history of  stroke).15  Quality 
initiatives such as screening for depression are likely to increase in coming years due to both 
the increasing focus on mental health care and the relative ease of  collecting structured 
process measures from electronic health records (EHRs).  For example, screening for clinical 
depression is included in the 2014 Adult Clinical Quality Core Measure for meaningful use 
incentives.16   However, the “optimum frequency” of  depression screening is unknown.12,17 
 A better understanding of  completion rates of  depression screening and correlates 
of  such screening in Medicare patients would have important implications for policy makers 
as they decide on quality measures to adopt for pay-for-quality incentives.18  In particular, 
information on the number of  individuals who would be affected by these quality indicators 
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can provide useful guidance regarding the population impact of  these interventions.  To our 
knowledge, there is no current information on either depression screening rates as a 
preventive measure, or as a measure for monitoring depression in Medicare patients in the 
peer-reviewed literature. Therefore, the objective of  this study is to identify the prevalence 
and correlates of  depression screening associated with quality measures and patient 
correlates of  meeting the quality indicator. 
!
Methods 
Study population  
 This report is based on the secondary-analysis of  retrospectively collected EHR data 
for 5,000 patients across 198 physicians working in 34 primary care practices in Maryland 
and Washington, D.C..  Physicians were Internal Medicine or Family Medicine specialists. For 
the main study, quota-random sampling was required for drawing the sample so that half  of  
the patients had at an Annual Wellness Visit (AWV) and half  did not have an AWV primary 
care visit during the study period (September 1, 2010- August 31, 2012).  AWV’s are a 
recently implemented annual preventive care visit for Medicare beneficiaries covering 14 
recommended preventive-care screenings, including a required depression screening during 
the patient’s initial AWV. 19-21   For this study, having an AWV is included as a variable in the 
analysis to take advantage of  this unique opportunity for understanding the impact of  policy 
initiatives to increase depression screening on meeting quality indicators.   
Data Collection 
 Clinicians used General Electronic Health’s Centricity EHR system implemented in 
2007.  This EHR system was designed for ambulatory office settings and can interface with 
practice management systems.  Scores from the Patient Heath Questionnaire (PHQ) 
screening instrument were collected from structured fields in the EHR.  The structured 
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fields allowed physicians to answer the first two questions (the PHQ-2), regarding 
Diagnostic and Statistical Manual’s (DSM-IV) two main symptoms of  major depression (i.e., 
depressed mood and/or anhedonia), and if  the patient answered positively to any one of  
these questions, continued on to the longer PHQ-9 template. In this manner, structured 
scores for both the PHQ-2 and the PHQ-9 were captured.  For purposes of  simplicity, the 
rest of  the manuscript will refer to both version of  the questionnaire as the PHQ-9.  Data 
on all PHQ-9 screens was collected between July 1, 2009 and November 30, 2012 if  a 
patient was selected into the study by having an index visit between September 1, 2010 and 
August 31, 2012. The patient’s AWV or preventive care visit that was used to determine 
eligibility to be part of  the parent study was identified as the patient’s index visit for this 
study.   
The PHQ-9 is a valid and reliable instrument for depression screening (sensitivity 
88%, specificity 88% for major depression in a general population) commonly used in 
general medical settings.22   A score greater than 5 is considered evidence of  mild 
depression, greater than 9 as moderate depression and greater than 15 as moderately severe 
depression.22 
Patient-level covariates included demographics (age, race, sex) and the patient’s active 
diagnosis as recorded by the provider.  Diagnosis was obtained from the patient’s full 
problem list, and determined to be active if  the diagnosis date was prior to the index date 
and either there was no stop date or the stop date was after the index date. Diagnoses were 
based on ICD-9 code definitions from the Medicare Chronic Conditions Data Warehouse.23  
Patients with two or more common chronic conditions (hyperlipidemia, hypertension, 
rheumatoid arthritis, diabetes, ischemic heart disease, chronic kidney disease, depression, 
osteoporosis, chronic obstructive pulmonary disorder, cancer, asthma, atrial fibrillation, 
stroke, or heart failure) were defined as having multimorbidity.  Exclusion criteria for 
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measures depression screening within a 4-month period24 and depression remission within a 
year14 were calculated using ICD-9 codes 296.7, 296.80 and 296.00 from the problem list.  
 Patients with depression were identified using the following ICD-9 codes: 296.21, 
296.22, 296.23, 296.30, 296.31, 296.31, 296.32, 296.33, 296.35, and 311. 
Quality Indicators 
 Quality of  depression care measures were identified in 2013 using the following 
databases, all of  which have a rigorous process of  reviewing measures for inclusion based on 
criteria such as importance and scientific soundness: National Quality Forum, Agency for 
Healthcare Research and Quality National Quality Measures Clearinghouse, Physician 
Quality Reporting System, and Electronic Health Record incentive program (Meaningful Use 
Stage 2).  Measures were included if  our data set contained all the necessary information to 
compile that quality measure.  
 The overall rate of  general screening for depression and six quality measures were 
calculated.  The specific measures were: the percent of  patients with a diagnosis of  major 
depression who had a depression screen at least once during a 4-month measurement period 
(“Depression management: screening within 4 months”);24 percent of  patients with a new 
diagnosis of  depression whose symptoms were reassessed by the use of  a quantitative 
symptom assessment tool (such as PHQ-9) within three months of  initiating treatment 
(“Depression reassessment: screening within 3 months of  treatment”);25 percent of  patients 
seen after a stroke who had a depression screen (“Screening after stroke”);15 and percent of  
patients with cardiovascular disease with documentation of  screening for depression 
(“Screening after heart disease”);26 percent of  patients with major depression or dysthymia 
or a PHQ-9 screen greater than 10 on the index visit, who had a 50 percent or greater 
reduction on their next PHQ-9 screen (“Screening for depression reduction”);13 and percent 
of  patients with major depression or dysthymia and a PHQ-9 screen score greater than 9 on 
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the index visit, who achieved remission at twelve months as demonstrated by a twelve month 
(+/- 30 days) PHQ-9 score of  less than five(“Screening for depression remission”).14 (Table 
1)  
Analysis 
 Descriptive analysis was conducted to assess the percentage of  patients who were 
screened for depression and summary statistics (e.g. mean, range).   
 Assessment of  completion of  the seven quality indicators was based on the 
denominator and numerator specifications of  each measure.  Three different periods 
(December 2010-February 2011; March 2011-June 2011; April 2012-August, 2012) were 
calculated to assess the sensitivity of  the results to variations in time period for the measure 
“depression screening within 4 months”.24  Since the results were similar across all time 
periods, the March-June 2011 results are reported.  
 To determine correlates of  meeting the measure’s numerator, multilevel logistic 
regressions were run for measures that had more than 100 patients in the denominator.  
Patient covariates were included as dichotomous variables: male versus female; 65 to 74 years 
of  age versus greater than or equal to 75 years; and non-AWV index visit versus AWV-index 
visit. Race was categorized into three large categories: white, black or other.   White race was 
set as the reference category since it was the largest. Multilevel regressions were run with the 
standard errors clustered first by the physician, and then by the site. However, since the 
results were similar, only clustering by site is shown.  
 Multivariable logistic regression analysis was used to determine the predictors of  
meeting quality indicators for the measures that had more than 100 patients in the 
denominator.  Standard errors were clustered by site for the multivariable logistic regression 
since clustering by site provided slightly better estimates in the bivariate analysis.  All results 




Patients who were sampled were on average 74 years old, 63% were white, 61% were 
female, and 48% had at least one AWV during the study period.  In sum, 705 individuals 
(14%) had a diagnosis of  depression within the study period.  Of  these individuals, 7 had a 
co-occurring diagnosis for bipolar disorder. 
General Screening 
In total, 869 people (17%) of  patients had at least one PHQ-9 score recorded in the 
EHR, of  which 69% (n=603) had a maximum score of  zero, indicating no depressive 
symptoms.  A small percentage of  patients scored greater than 5 on any screen, an indication 
of  at least having moderate depression symptoms (n=92; 11%).  Very few patients (n=47; 
5%) had a PHQ-9 score greater than 10 on any screen.  
Persons who were screened at least once for depression, were likely to be screened 
more than once.  Eighty-two percent of  patients screened had a second screen (n=716). 
Seventy-eight percent of  patients who had at least one screen had a subsequent screen 
within one year of  the index visit.  Likelihood of  a subsequent screen differed significantly 
by visit type, with a higher percentage of  non-AWV patients receiving a follow-up screen (93 
percent compared to 63 percent).  
Depression management: screening within 4 months 
A total of  698 patients with a diagnosis of  depression and no diagnosis of  bipolar 
disease were included in this analysis.  Overall, 69 (10%) of  these individuals had at least one 
depression screen during the study period.  
Depression reassessment: screening within 3 months of  treatment 
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 Two-hundred and seventy-five patients who had a clinical diagnosis of  depression 
within one year of  their index visit were included in the assessment for this indicator.  Of  
these, 42 (15%) of  newly diagnosed patients had a depression screen within 3 months (90 
days) of  their diagnosis. 
Screening after stroke 
 Three-hundred and three (6%) patients with a clinical diagnosis of  stroke were 
included in assessment of  this quality indicator.  Of  these, 64 patients (21%) had a 
depression screen.   
Screening after heart disease 
 Two-hundred and fifty-nine (5%) patients had a clinical diagnosis for heart disease.  
Of  these, 49 patients (21%) had a depression screen. 
Screening for depression reduction 
 In total, 667 patients (13%) either had a diagnosis of  depression on or prior to the 
index visit, or had a PHQ-9 screen greater than 10 on their index visit. Of  these patients, 68 
(10%) had a 50 percent reduction in a subsequent PHQ-9 score during the study period.  Of  
the few patients (n=9) that had a PHQ-9 screen greater than 10 on the index visit, two had a 
reduction of  50% on their subsequent screen. 
Depression remission at 12 months 
  Forty-seven patients had a PHQ-9 score greater than 10 during the study period.  
Of  which, 30 patients also had a diagnosis of  depression.  Twenty-three patients (77%) of  
the 30 met the quality indicator criterion of  a subsequent depression score less than 5 within 
12 months of  the initial PHQ-9 score greater than 10.    
Correlates of  meeting quality indicators 
 Correlates of  meeting different quality measures varied by measure.  In the 
unadjusted regressions, black patients were consistently more likely to meet quality measures 
!56
compared to whites even when controlling for site clustering.  However, this trend was only 
significant for the depression management, depression reassessment and screening after 
heart disease measures(AOR: 2.63, 95%CI: 1.15-6.00; AOR:4.11, 95%CI:1.17-14.48; and 
AOR:5.23,95%CI:1.35-2.00, respectively).  Further, the odds of  black patients meeting the 
quality measure more than white patients held in the multivariable model for both the 
depression reassessment and screening after heart disease models (AOR: 4.19; 95%CI: 
1.16-15.19; AOR:5.57, 95%CI:1.37-22.57).   
 Having an AWV visit increased the odds of  meeting the depression reduction 
measure.  In the multivariable model, patients with an AWV compared to patients without an 
AWV had an adjusted odds ratio of  3.93 for meeting the depression reduction measure after 
accounting for age, race, sex and site clustering (95%CI: 1.46-10.57).  However, having an 
AWV did not significantly change the odds of  meeting any other quality measure in the 
multivariable models; and it decreased the odds of  depression screening in the bivariate 
model for the general depression measure (OR:0.42, 95%CI:0.31-0.58). 
 In the multivariable model, controlling for clustering, patients older than 75 years 
were 41% more likely to meet the general depression screening measure (AOR: 1.41; 95%CI: 
1.05-1.90) but there was no significant difference for the other measures.  Female gender was 
not significantly correlated with any of  the measures.  Correlates for the measure 
“depression remission at 12 months” could not be determined due to small denominator 
sample size.(Table 2) 
!
Discussion 
 Overall, screening for depression among Medicare patients in a diverse network of  
primary care practices using an EHR was low, at 17%.  Eighty-two percent of  patients who 
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were screened at least once for depression were screened more than once.  Performance on 
quality measures was generally low, varying from 10% for screening for depression reduction 
to 77% for depression remission at 12 months.  The variability in meeting the quality 
measures suggests that incentives for some measures (e.g. use of  the PHQ-9 tool) would 
have more room for improvement than measures that are already met by a larger proportion 
of  patients.  In our multivariable model, only black race compared to white race significantly 
increased the odds of  meeting two of  the quality measure numerator criteria (i.e. depression 
reduction and screening after heart disease) (AOR: 4.19; 95%CI: 1.16-15.19; AOR: 5.57, 
95%CI: 1.37-22.57, respectively).  Two additional patient characteristics significantly 
impacted the odds of  meeting a quality measure in the multivariable models.  Patients 75 
years of  age or older had increased odds of  general depression screening compared to 
patients less than 75 while controlling for AWV status, sex, and race (AOR: 1.41; 95%CI: 
1.05-1.90).  Patients with an AWV had higher odds of  meeting the quality measure than non-
AWV patients in the screening for depression reduction measure AOR: 3.93; 95%CI: 
1.46-10.57), 
 Our results in a Medicare population are similar to results from Minnesota’s 
Community Measurement 2012 Health Care Quality report which had a 5.1% average in a 
state-wide general population’s ability to meet the depression remission measure .27  Our 
study found higher rates of  depression remission at 12 months (77%); however, as noted 
above, confidence in this finding is low since only a very small number of  patients qualified 
for the measure (47 people or 1% of  the study population).  Conversely, our study found 
fairly similar results to Minnesota’s state-wide depression response rate within 12 months 
(10% compared to 8.7% for this study and Minnesota, respectively).  The concern with both 
the depression remission and response measures is that depressed patients often have cycles 
of  remission and reoccurrence: over half  of  patients with a single episode of  depression 
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have a recurrent episode; and the second episode of  depression is usually within 5 years of  
the first.28  Importantly, previous work has found that routinely reviewing patients PHQ-9 
scores for patients with at least mild depression was associated with increased odds of  
patients’ depression responding to treatment.29  
Measuring the impact of  processes of  care for patients with depression on 
meaningful patient outcomes is difficult.  A systematic review of  primary care in the United 
Kingdom found no evidence that assessing depression severity using a structured tool and 
subsequent treatment based on that assessment resulted in improved patient outcomes.30  In 
the U.S., depression screening was found effective only if  “staff-assisted depression care 
supports are in place”31, and that caveat is not necessarily being implemented in clinics along 
with the quality measures.  There is some evidence of  over-diagnosis of  depression by 
clinicians in the community setting.32  With, 78% of  patients who were diagnosed by their 
clinician as depressed but did not meet the criteria of  major depression, used a prescription 
psychotic medication.32  Further, there is only moderate agreement between physicians and 
patients regarding the degree to which a patient’s depression has improved over time.33   
Structured tools, such as the PHQ-9, are being used for tracking depression severity,
34 even though they were not initially validated for that purpose.22  Previous work has found 
that physicians are concerned about the impact of  using a structured depression screener on 
their relationship with patients, and are uncertain when best to employ the screener within 
the consultation.35  These concerns may be a reason why few patients were found to be 
screened for depression, despite the explicit opportunity for screening for half  of  the sample 
because of  their AWV.  Further, the repeat screening of  a high percentage of  people with 
low PHQ-9 scores suggests particular clinicians have identified workflows to ameliorate 
these depression screening barriers. 
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 For older-adults, especially those with multimorbidity, choosing measures that may 
meet their particular preferences may be a better goal than widespread screening.36  
Especially if, as found in our study, a large proportion of  repeated screening is being 
conducted for patients who are not reporting symptoms of  depression on a standardized 
tool.  Indeed, when choosing which quality measures to incentivize, thought should be given 
to the potential role of  stigma associated with depression.37  Eidus and colleagues suggested 
that quality measures should be associated with “high-leverage” activities such as care-
coordination, team-based care, and the establishment of  a therapeutic environment that 
could result in larger impact on patient outcomes.38 These types of  high-leverage activities 
are valuable for patients with depression and multimorbidity,34 and may be an important 
contributor to high quality care.  Organizations promoting depression screening, such as 
Medicare, should consider integrating incentives for both screening and high-leverage 
activities together.  Medicare’s AWV benefit20 takes steps towards this integration by having 
patients identify to their primary care physician all physicians from which medical care is 
being received, but further integrations should be considered. 
 This study had several limitations.  Depression screening data was pulled from 
structured EHR fields, and there is the possibility that more screening would have been 
captured in unstructured fields, such as clinician notes.  However, incentives for quality 
measure will likely be based on such structured reports.  A second major limitation of  this 
study is the low prevalence of  patients in the denominator for some of  the quality measures 
in this study population--particularly the low number of  patients who had a PHQ-9 score 
greater than 9.  The findings need to be corroborated in larger samples.  Further, the small 
number of  patients in the denominator does provide useful information to policy-makers 




 Only a small proportion of  Medicare patients received the recommended screening 
and follow-up care needed to meet quality measures for depression monitoring and follow-
up.  Moreover, the denominator population for each of  six quality measures assessed was 
quite small, ranging from 14% to 1% of  this sample of  5,000 patients across 34 primary care 
practices.  In the multivariable models controlling for site clustering, there was no consistent 
patient characteristic that was correlated with screening.  Further evaluation and validation 
of  measures of  depression care quality should be conducted before these measures are 
implemented widely.  While identifying patients with depression and providing care that 
helps to mitigate depression symptoms is important, caution should be taken in using quality 
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Table 1. Quality Measures Associated with Depression Care in the Ambulatory Care Setting Used in This 
Study
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Adults age 18 and older 
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major depression or 
dysthymia and an initial 
PHQ-9 score greater 
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Abbreviations: AOR = Adjusted odds ratio 
* indicates significance at the p≤0.05 level
** indicates significance at the p≤0.01 level 
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Multivariable model with site clustering
Age ≥75 years 




































- - 5.57* 1.37- 
22.57
Other race 









- - 6.46 0.34- 
122.9
3














Throughout this study, depression screening was found to be low.  With overall 
depression screening found to be 17%.  When assessing the impact of  Medicare’s Annual 
Wellness Visit (AWV) on depression screening, low screening was also found with 15% of  
non-AWV patients and 10% of  AWV patients receiving a screen on their index visit.  
Depression screening was then compared to smoking screening to see if  preventive 
screening for a physical health outcome was similarly low.  Instead, smoking screening was 
found to occur at ~90% of  patients’ visits, and depression screening almost never occurred 
in isolation of  smoking screening.  These results show that there is an inequity in preventive 
screening for depression compared to smoking screening.  Further, a policy requiring 
depression screening during a specific visit was insufficient to increase depression screening 
to rates similar to smoking screening.   
There was also a clear site effect on screening behaviors.  One site (site 34) screened 
a majority of  their patients for depression on the patients’ index visit, regardless of  index 
visit type.  Six sites never screened any of  their AWV index patients for depression.  Further, 
when screening was assessed longitudinally, site 34 continued to screen patients for both 
depression and smoking at a high rate.  Indeed, 82% of  patients screened for depression at 
least once were screened a second time.  This is especially notable since 63% of  patients 
screened at least once for depression scored a zero on all depression screens. Demonstrating 
that there was am impact of  clinic proclivity for screening on depression screening rates.  
These findings suggest that the efficiency of  different clinic workflows for preventive-care 
screening should be considered, especially when trying to meet depression quality of  care 
indicators.   
In paper 3, the the current quality of  depression care based on 7 quality measures 
was evaluated.  Overall, the rate of  measure completion was variable, ranging between 10% 
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to 77%.  Very few patients (n=47) had a depression screening score >9 on any screen.  
Indicating that among people screened, scores indicative of  depression on the standard 
screening tool was low.  Further evaluation and validation of  measures of  depression care 
quality should be conducted before these measures are implemented widely.  Especially since 
in this study, the denominator population for each measure was small, ranging from 14% to 
1% of  the sample; and good quality measures should impact a large proportion of  the target 
population to increase care efficiency.   Use of  patient-reported measures as quality 
indicators will increase with the proliferation of  pay-for-quality initiatives.  For example, 
clinical quality measures associated with the Meaningful Use program include depression 
screening.1  Therefore, understanding the impact of  using patient-reported depression 
screening as a quality indicator for mental health care, and assessing the value of  widespread 
depression screening is essential. 
 This work has several strengths. First, the large number of  patients, across 34 
primary care practices, with data collected over a two-year period provide substantial external 
generalizability for this study.  This strength is tempered since data was collected in one state 
under one medical group.  Yet, the heterogeneity of  depression screening practices suggest 
that variation within this medical group may be comparable of  general variation in screening 
practices.  Another strength is the current policy relevance of  this study.  To my knowledge, 
this is the first study that evaluates the impact of  Medicare’s AWV on depression screening.  
This study only focused on screening using the Patient Health Questionnaire, and structured 
data fields in the electronic health record, which may have underestimated the true amount 
of  screening.  Importantly, quality measures associated with Meaningful Use will be collected 
through structured data fields.  Therefore, this study’s use of  structured data fields increases 
the relevance of  these findings since they are reflective of  data reported to obtain 
Meaningful Use incentives.  A major limitation of  this study is that I am unable to determine 
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how screening was administered within each clinic.  Clinic workflow associated with 
screening may be an important factor in depression screening rates.  Future work should 
focus on which clinic workflows associated with depression screening provide optimal 
quality of  care. 
 Depression is an important disease that is treatable.2-5  Screening for depression in 
accordance to evidenced-based practice is important,6 but assuring the structure of  
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Appendix:   !
I. Additional information for Paper #1: Impact of  Medicare Annual Wellness Visits 
on Depression Screening !
ICD-9 codes used in the analysis 
Four representative diagnoses known to be prevalent and strongly associated with depression 
were included in the analysis: cancer (ICD-9 codes 174.0, 174.1, 174.3-174.9, 175.0, 175.9, 
153.0-153.8, 154.0, 185, 233.4, 162.2-162.5, 162.8, 162.9, 231.2, V10.11, 182.0, 233.2, 
V10.42), diabetes (ICD-9 codes 250.00, 250.01, 250.02, 250.40, 250.42, 250.50, 250.70, 
250.72, 250.80, 250.81, 250.82, 250.90, 250.92, 362.01-362.04 362.06, 366.41), hypertension 
(ICD-9 codes 401.0, 401.1, 401.9, 402.00, 402.01, 402.10, 402.90, 402.91, 403.00, 403.10, 
403.90, 404.00-404.03, 404.10-404.13, 404.90-404.93, 405.01, 405.09, 405.11, 405.19, 405.99, 
437.2) and Alzheimer’s dementia (ICD-9 codes 290.0, 290.10-290.13, 290.20, 290.21, 290.3, 




*Models were run using step-wise analysis.  Model numbers correspond to the variables 
listed in the top row of  Tables B-D. 
!











1 3635.582 -20.855 0.006 -1814.791 -655.09215 -526.91523
2 3639.423 -12.526 0.005 -1814.712 -654.19167 -526.66773
3 3634.519 -12.942 0.007 -1810.260 -652.77041 -524.81996
4 3270.233 -366.253 0.106 -1625.116 -650.83069 -523.77056
5 3649.842 -5.132 0.002 -1809.921 -652.74123 --
6a 3287.137 -352.374 0.102 -1623.568 -650.56623 -523.8177
6b 3272.734 -359.265 0.106 -1624.367 -650.60216 --
7 3282.470 -356.775 0.103 -1621.235 -650.07796 -523.30721
8 3288.310 -351.200 0.101 -1624.155 -650.04827 -523.11455
9 3287.663 -351.848 0.101 -1623.831 -648.89835 -522.79367
10 3287.149 -352.361 0.102 -1623.574 -650.43006 -523.71746
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Table C. The impact of  index visit on depression screening: patient level with step-wise added confounders 
and physician clustering   
Model  ICC Index 
Visit  
(ref  = 
non-
AWV)
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Table D. The impact of  index visit on depression screening: patient level with step-wise added confounders 
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Table E. Detailed Physician Correlation Information for Multilevel Logistic Regressions
Physician Variance Physician ICC
Bivariate Analysis
AWV index Visit 18.05 ( 11.0, 29.73) 0.85 (.77, .90)
Female 17.93 ( 10.90,  29.50) 0.84 (.77, .90)
Age 17.81 ( 10.83 29.30) 0.84 (.77, .90)
Race 17.79 (10.79, 29.34) 0.84 (.77, .90)
Sensitivity analysis 
Multivariate physician 
clustering no site 34
8.51 (4.41, 16.41) 0.72 (0.57, 0.83)
Multivariate physician 
clustering site 34
0.96 (0.27, 3.43) 0.23 (0.08, 0.51)
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II. Paper #2: Depression screening in primary care: either with smoking-screening 
or not at all 








Table F. Cross-sectional analysis: Impact of  Multimorbidity, History of  Stroke and Depression on 
receipt of  smoking and depression screening
Unadjusted Model Adjusted for Age, Race & 
Sex







No screening 1.07  
(0.81-1.41)
0.620 1.48  
(1.11-1.97)
0.007
Smoking status screening only 0.60  
(0.50-0.73)
<0.001 0.94  
(0.76-0.15)
0.537
History of  stroke No screening 1.22  
(0.80-1.89)
0.356 1.44  
(0.93-2.24)
0.105






















Table G. Cross-sectional analysis: Impact of  Multimorbidity, History of  Stroke and Depression on 
receipt of  smoking and depression screening with no site clustering
Unadjusted Model Adjusted for Age, Race 
& Sex







No screening versus any screening  










No screening versus smoking screening 










No screening versus both screenings 








Smoking screening versus both 
screenings  










No screening or smoking screening 
versus both screening  










History of  
stroke
No screening versus any screening  








No screening versus smoking screening 








No screening versus both screenings 








Smoking screening versus both 
screenings  








No screening or smoking screening 
versus both screening  









No screening versus any screening  









No screening versus smoking screening 







No screening versus both screenings 








Smoking screening versus both 
screenings  








No screening or smoking screening 
versus both screening  








Table G. Cross-sectional analysis: Impact of  Multimorbidity, History of  Stroke and Depression on 
receipt of  smoking and depression screening with no site clustering
Unadjusted Model Adjusted for Age, Race 
& Sex










Table H.  Quality Measure Completion Rates
Measure Denominator Numerator Measure completion
General depression screening 5000 869 17%
Depression management 698 69 10%
Depression reassessment 275 42 15%
Screening after stroke 303 64 21%
Screening after heart disease 259 49 21%
Screening for depression reduction 667 68 10%



































AOR 95%  
CI
Age ≥75 years 













AWV index visit  





































- - 9.19** 3.81- 
22.16
























Screening after heart 
disease 
(N=222)
AOR 95% CI AOR 95% CI AOR 95% CI
Age ≥75 years 
(ref  = <75 years)
1.21 0.90- 1.63 1.31 0.44-3.88 1.28 0.37-4.32
AWV index visit  
(ref  = non-
AWV)
0.41** 0.30 - 0.57 0.83 0.21-3.21 0.75 0.18-3.15
Black race 
(ref= White)
1.15 0.78-1.70 3.82* 1.11-13.10 3.71 .87-15.82
Other race 
(ref  = White)
0.46 0.16 - 1.34 1.72 0.15-20.01 5.15 0.30-89.03
 Female  
(ref  =male)
0.99 0.74 - 1.34 0.94 0.28-3.20 0.81 0.23-2.90
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